Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 76

1.

Identification of housekeeping genes for microRNA expression analysis in kidney tissues of Pkd1 deficient mouse models.

Muñoz JJ, Anauate AC, Amaral AG, Ferreira FM, Meca R, Ormanji MS, Boim MA, Onuchic LF, Heilberg IP.

Sci Rep. 2020 Jan 14;10(1):231. doi: 10.1038/s41598-019-57112-4.

2.

Expression of vitamin D receptor, CYP27B1 and CYP24A1 hydroxylases and 1,25-dihydroxyvitamin D3 levels in stone formers.

Melo TL, Esper PLG, Zambrano LI, Ormanji MS, Rodrigues FG, Heilberg IP.

Urolithiasis. 2020 Feb;48(1):19-26. doi: 10.1007/s00240-019-01163-9. Epub 2019 Nov 6.

PMID:
31696245
3.

Association of Vitamin D Levels With Kidney Volume in Autosomal Dominant Polycystic Kidney Disease (ADPKD).

Vendramini LC, Dalboni MA, de Carvalho JTG Jr, Batista MC, Nishiura JL, Heilberg IP.

Front Med (Lausanne). 2019 May 24;6:112. doi: 10.3389/fmed.2019.00112. eCollection 2019.

4.

Searching for mutations in the HNF1B gene in a Brazilian cohort with renal cysts and hyperglycemia.

Dotto RP, Santana LS, Lindsey SC, Caetano LA, Franco LF, Moisés RCMS, Sa JR, Nishiura JL, Teles MG, Heilberg IP, Dias-da-Silva MR, Giuffrida FMA, Reis AF.

Arch Endocrinol Metab. 2019 May-Jun;63(3):250-257. doi: 10.20945/2359-3997000000138. Epub 2019 May 2.

5.

Caffeine Accelerates Cystic Kidney Disease in a Pkd1-Deficient Mouse Model.

Meca R, Balbo BE, Ormanji MS, Fonseca JM, Iannuzzi LR, Santana Costa E, Onuchic LF, Heilberg IP.

Cell Physiol Biochem. 2019;52(5):1061-1074. doi: 10.33594/000000072.

6.

Bartter syndrome: causes, diagnosis, and treatment.

Cunha TDS, Heilberg IP.

Int J Nephrol Renovasc Dis. 2018 Nov 9;11:291-301. doi: 10.2147/IJNRD.S155397. eCollection 2018. Review.

7.

Defining metabolic activity of nephrolithiasis - Appropriate evaluation and follow-up of stone formers.

Wollin DA, Kaplan AG, Preminger GM, Ferraro PM, Nouvenne A, Tasca A, Croppi E, Gambaro G, Heilberg IP.

Asian J Urol. 2018 Oct;5(4):235-242. doi: 10.1016/j.ajur.2018.06.007. Epub 2018 Jun 26. Review.

8.

Fish Oil Supplementation Reduces Inflammation but Does Not Restore Renal Function and Klotho Expression in an Adenine-Induced CKD Model.

Henao Agudelo JS, Baia LC, Ormanji MS, Santos ARP, Machado JR, Saraiva Câmara NO, Navis GJ, de Borst MH, Heilberg IP.

Nutrients. 2018 Sep 11;10(9). pii: E1283. doi: 10.3390/nu10091283.

9.

Influence of nutritional status, laboratory parameters and dietary patterns upon urinary acid excretion in calcium stone formers.

Tessaro CZW, Ramos CI, Heilberg IP.

J Bras Nefrol. 2018 Jan-Mar;40(1):35-43. doi: 10.1590/2175-8239-JBN-3814. Epub 2018 Apr 26. English, Portuguese.

10.

Kidneys and women's health: key challenges and considerations.

Ashuntantang GE, Garovic VD, Heilberg IP, Lightstone L.

Nat Rev Nephrol. 2018 Mar;14(3):203-210. doi: 10.1038/nrneph.2017.188. Epub 2018 Jan 30.

11.

Bone turnover after bariatric surgery.

Melo TL, Froeder L, Baia LDC, Heilberg IP.

Arch Endocrinol Metab. 2017 Jul-Aug;61(4):332-336. doi: 10.1590/2359-3997000000279. Epub 2017 Jul 13.

12.

Hyperoxaluria in a Model of Mini-Gastric Bypass Surgery in Rats.

Ormanji MS, Korkes F, Meca R, Ishiy CSRA, Finotti GHC, Ferraz RRN, Heilberg IP.

Obes Surg. 2017 Dec;27(12):3202-3208. doi: 10.1007/s11695-017-2725-3.

PMID:
28550437
13.

Whey protein and albumin effects upon urinary risk factors for stone formation.

Hattori CM, Tiselius HG, Heilberg IP.

Urolithiasis. 2017 Oct;45(5):421-428. doi: 10.1007/s00240-017-0975-0. Epub 2017 Mar 22.

PMID:
28331937
14.

N-acetylcysteine protects against star fruit-induced acute kidney injury.

Shimizu MH, Gois PH, Volpini RA, Canale D, Luchi WM, Froeder L, Heilberg IP, Seguro AC.

Ren Fail. 2017 Nov;39(1):193-202. doi: 10.1080/0886022X.2016.1256315. Epub 2016 Nov 15.

15.

Metabolic diagnosis and medical prevention of calcium nephrolithiasis and its systemic manifestations: a consensus statement.

Gambaro G, Croppi E, Coe F, Lingeman J, Moe O, Worcester E, Buchholz N, Bushinsky D, Curhan GC, Ferraro PM, Fuster D, Goldfarb DS, Heilberg IP, Hess B, Lieske J, Marangella M, Milliner D, Preminger GM, Reis Santos JM, Sakhaee K, Sarica K, Siener R, Strazzullo P, Williams JC; Consensus Conference Group.

J Nephrol. 2016 Dec;29(6):715-734. Epub 2016 Jul 25. Review.

16.

Treatment of patients with uric acid stones.

Heilberg IP.

Urolithiasis. 2016 Feb;44(1):57-63. doi: 10.1007/s00240-015-0843-8. Epub 2015 Dec 8. Review.

PMID:
26645868
17.

Adult presentation of Bartter syndrome type IV with erythrocytosis.

Heilberg IP, Tótoli C, Calado JT.

Einstein (Sao Paulo). 2015 Oct-Dec;13(4):604-6. doi: 10.1590/S1679-45082015RC3013. Epub 2015 Oct 30. English, Portuguese.

18.

Phosphate and FGF-23 homeostasis after kidney transplantation.

Baia LC, Heilberg IP, Navis G, de Borst MH; NIGRAM investigators.

Nat Rev Nephrol. 2015 Nov;11(11):656-66. doi: 10.1038/nrneph.2015.153. Epub 2015 Sep 29. Review.

PMID:
26416497
19.

Overweight and body fat are predictors of hypovitaminosis D in renal transplant patients.

Baxmann AC, Menon VB, Medina-Pestana JO, Carvalho AB, Heilberg IP.

Clin Kidney J. 2015 Feb;8(1):49-53. doi: 10.1093/ckj/sfu120. Epub 2014 Nov 17.

20.

Urolithiasis and pregnancy.

Korkes F, Rauen EC, Heilberg IP.

J Bras Nefrol. 2014 Jul-Sep;36(3):389-95. Review. English, Portuguese.

21.

Fish and omega-3 fatty acid intake in relation to circulating fibroblast growth factor 23 levels in renal transplant recipients.

Baia LC, Van den Berg E, Vervloet MG, Heilberg IP, Navis G, Bakker SJ, Geleijnse JM, Kromhout D, Soedamah-Muthu SS, De Borst MH; NIGRAM consortium.

Nutr Metab Cardiovasc Dis. 2014 Dec;24(12):1310-6. doi: 10.1016/j.numecd.2014.06.006. Epub 2014 Jun 23.

22.

Determination of urinary lithogenic parameters in murine models orthologous to autosomal dominant polycystic kidney disease.

Ferraz RR, Fonseca JM, Germino GG, Onuchic LF, Heilberg IP.

Urolithiasis. 2014 Aug;42(4):301-7. doi: 10.1007/s00240-014-0664-1. Epub 2014 May 10.

23.

Exercise capacity in polycystic kidney disease.

Reinecke NL, Cunha TM, Heilberg IP, Higa EM, Nishiura JL, Neder JA, Almeida WS, Schor N.

Am J Kidney Dis. 2014 Aug;64(2):239-46. doi: 10.1053/j.ajkd.2014.03.014. Epub 2014 Apr 29.

PMID:
24787761
24.

Expression of fibroblast growth factor 23, vitamin D receptor, and sclerostin in bone tissue from hypercalciuric stone formers.

Menon VB, Moysés RM, Gomes SA, de Carvalho AB, Jorgetti V, Heilberg IP.

Clin J Am Soc Nephrol. 2014 Jul;9(7):1263-70. doi: 10.2215/CJN.10030913. Epub 2014 Apr 24.

25.

Pain determinants of pain in autosomal dominant polycystic kidney disease.

Nishiura JL, Eloi SR, Heilberg IP.

J Bras Nefrol. 2013 Jul-Sep;35(3):242-3. doi: 10.5935/0101-2800.20130038.

26.

The effect of sodium bicarbonate upon urinary citrate excretion in calcium stone formers.

Pinheiro VB, Baxmann AC, Tiselius HG, Heilberg IP.

Urology. 2013 Jul;82(1):33-7. doi: 10.1016/j.urology.2013.03.002. Epub 2013 Apr 18.

PMID:
23602798
27.

Optimum nutrition for kidney stone disease.

Heilberg IP, Goldfarb DS.

Adv Chronic Kidney Dis. 2013 Mar;20(2):165-74. doi: 10.1053/j.ackd.2012.12.001. Review.

PMID:
23439376
28.

Response to dietary oxalate after bariatric surgery.

Froeder L, Arasaki CH, Malheiros CA, Baxmann AC, Heilberg IP.

Clin J Am Soc Nephrol. 2012 Dec;7(12):2033-40. doi: 10.2215/CJN.02560312. Epub 2012 Sep 27.

29.

Caffeine intake by patients with autosomal dominant polycystic kidney disease.

Vendramini LC, Nishiura JL, Baxmann AC, Heilberg IP.

Braz J Med Biol Res. 2012 Sep;45(9):834-40. Epub 2012 Jul 19.

30.

Noncitrus alkaline fruit: a dietary alternative for the treatment of hypocitraturic stone formers.

Baia Lda C, Baxmann AC, Moreira SR, Holmes RP, Heilberg IP.

J Endourol. 2012 Sep;26(9):1221-6. doi: 10.1089/end.2012.0092. Epub 2012 Jun 4.

PMID:
22500592
31.

Simplified estimates of ion-activity products of calcium oxalate and calcium phosphate in mouse urine.

Tiselius HG, Ferraz RR, Heilberg IP.

Urol Res. 2012 Aug;40(4):285-91. doi: 10.1007/s00240-011-0443-1. Epub 2011 Dec 27.

PMID:
22200737
32.

Costs for in hospital treatment of urinary lithiasis in the Brazilian public health system.

Korkes F, Silva Ii JL, Heilberg IP.

Einstein (Sao Paulo). 2011 Dec;9(4):518-22. doi: 10.1590/S1679-45082011GS2143. English, Portuguese.

33.

Anxiety, depression, and quality of life in patients with familial glomerulonephritis or autosomal dominant polycystic kidney disease.

de Barros BP, Nishiura JL, Heilberg IP, Kirsztajn GM.

J Bras Nefrol. 2011 Apr-Jun;33(2):120-8. English, Portuguese.

34.

Translation, cultural adaptation and aplication of a pain questionnaire for patients with polycystic kidney disease.

Eloi SR, Nishiura JL, Heilberg IP.

J Bras Nefrol. 2010 Dec;32(4):386-99. English, Portuguese.

35.

Phyllanthus niruri as a promising alternative treatment for nephrolithiasis.

Boim MA, Heilberg IP, Schor N.

Int Braz J Urol. 2010 Nov-Dec;36(6):657-64; discussion 664. Review.

36.

The role of host factors and bacterial virulence genes in the development of pyelonephritis caused by Escherichia coli in renal transplant recipients.

Siliano PR, Rocha LA, Medina-Pestana JO, Heilberg IP.

Clin J Am Soc Nephrol. 2010 Jul;5(7):1290-7. doi: 10.2215/CJN.06740909. Epub 2010 May 6.

37.

Vitamin D receptor and calcium-sensing receptor gene polymorphisms in hypercalciuric stone-forming patients.

Ferreira LG, Pereira AC, Heilberg IP.

Nephron Clin Pract. 2010;114(2):c135-44. doi: 10.1159/000254386. Epub 2009 Nov 3.

PMID:
19887834
38.

Evaluation of nephrolithiasis in autosomal dominant polycystic kidney disease patients.

Nishiura JL, Neves RF, Eloi SR, Cintra SM, Ajzen SA, Heilberg IP.

Clin J Am Soc Nephrol. 2009 Apr;4(4):838-44. doi: 10.2215/CJN.03100608. Epub 2009 Apr 1.

39.

Effects of calcium supplementation on body weight reduction in overweight calcium stone formers.

Menon VB, Baxmann AC, Froeder L, Martini LA, Heilberg IP.

Urol Res. 2009 Jun;37(3):133-9. doi: 10.1007/s00240-009-0187-3. Epub 2009 Mar 27.

PMID:
19326108
40.

Effects of Lactobacillus casei and Bifidobacterium breve on urinary oxalate excretion in nephrolithiasis patients.

Ferraz RR, Marques NC, Froeder L, Menon VB, Siliano PR, Baxmann AC, Heilberg IP.

Urol Res. 2009 Apr;37(2):95-100. doi: 10.1007/s00240-009-0177-5. Epub 2009 Feb 12.

PMID:
19214493
41.

RANKL is a mediator of bone resorption in idiopathic hypercalciuria.

Gomes SA, dos Reis LM, Noronha IL, Jorgetti V, Heilberg IP.

Clin J Am Soc Nephrol. 2008 Sep;3(5):1446-52. doi: 10.2215/CJN.00240108. Epub 2008 May 14.

42.

Influence of muscle mass and physical activity on serum and urinary creatinine and serum cystatin C.

Baxmann AC, Ahmed MS, Marques NC, Menon VB, Pereira AB, Kirsztajn GM, Heilberg IP.

Clin J Am Soc Nephrol. 2008 Mar;3(2):348-54. doi: 10.2215/CJN.02870707. Epub 2008 Jan 30.

43.

Usefulness of a quick decalcification of bone sections embedded in methyl methacrylate[corrected]: an improved method for immunohistochemistry.

Gomes SA, dos Reis LM, de Oliveira IB, Noronha IL, Jorgetti V, Heilberg IP.

J Bone Miner Metab. 2008;26(1):110-3. Epub 2008 Jan 10.

PMID:
18095073
44.

A critical appraisal of the radiological evaluation of nephrocalcinosis.

Cheidde L, Ajzen SA, Tamer Langen CH, Christophalo D, Heilberg IP.

Nephron Clin Pract. 2007;106(3):c119-24. Epub 2007 May 22.

PMID:
17522474
45.

Renal stone disease: Causes, evaluation and medical treatment.

Heilberg IP, Schor N.

Arq Bras Endocrinol Metabol. 2006 Aug;50(4):823-31. Review.

PMID:
17117307
46.

Severe hyperkalemic type 4 renal tubular acidosis after kidney transplantation: a case report.

Rangel EB, Gomes SA, Machado PG, dos Santos BF, Pestana JO, Pacheco-Silva A, Heilberg IP.

Transplant Proc. 2006 Nov;38(9):3112-5.

PMID:
17112912
47.

Preservation of urine samples for metabolic evaluation of stone-forming patients.

Ferraz RR, Baxmann AC, Ferreira LG, Nishiura JL, Siliano PR, Gomes SA, Moreira SR, Heilberg IP.

Urol Res. 2006 Oct;34(5):329-37. Epub 2006 Aug 4.

PMID:
16896690
48.

Immobilization and hypercalciuria in children.

Korkes F, Segal AB, Heilberg IP, Cattini H, Kessler C, Santili C.

Pediatr Nephrol. 2006 Aug;21(8):1157-60. Epub 2006 Jul 4.

PMID:
16819644
49.

Bone disease in idiopathic hypercalciuria.

Heilberg IP, Weisinger JR.

Curr Opin Nephrol Hypertens. 2006 Jul;15(4):394-402.

PMID:
16775454
50.

Effects of creatine supplementation on body composition and renal function in rats.

Ferreira LG, De Toledo Bergamaschi C, Lazaretti-Castro M, Heilberg IP.

Med Sci Sports Exerc. 2005 Sep;37(9):1525-9.

PMID:
16177604

Supplemental Content

Loading ...
Support Center